MENU

Scinai Immunotherapeutics Ltd. - American Depositary Shares (NQ:SCNI)

1.410 -0.060 (-4.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 97,514
Open 1.500
Bid (Size) 1.350 (400)
Ask (Size) 1.370 (100)
Prev. Close 1.470
Today's Range 1.350 - 1.500
52wk Range 1.430 - 16.30
Shares Outstanding 461,285,824
Dividend Yield N/A

Performance

YTD
-80.7%
-80.7%
1 Month
-43.6%
-43.6%
3 Month
-47.6%
-47.6%
6 Month
-74.6%
-74.6%
1 Year
-88.2%
-88.2%

More News

Read More

Frequently Asked Questions

Is Scinai Immunotherapeutics Ltd. - American Depositary Shares publicly traded?
Yes, Scinai Immunotherapeutics Ltd. - American Depositary Shares is publicly traded.
What exchange does Scinai Immunotherapeutics Ltd. - American Depositary Shares trade on?
Scinai Immunotherapeutics Ltd. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The ticker symbol for Scinai Immunotherapeutics Ltd. - American Depositary Shares is SCNI on the Nasdaq Stock Market
What is the current price of Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The current price of Scinai Immunotherapeutics Ltd. - American Depositary Shares is 1.410
When was Scinai Immunotherapeutics Ltd. - American Depositary Shares last traded?
The last trade of Scinai Immunotherapeutics Ltd. - American Depositary Shares was at 09/29/26 04:00 PM ET
What is the market capitalization of Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The market capitalization of Scinai Immunotherapeutics Ltd. - American Depositary Shares is 650.41M
How many shares of Scinai Immunotherapeutics Ltd. - American Depositary Shares are outstanding?
Scinai Immunotherapeutics Ltd. - American Depositary Shares has 650M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
TOP
Email a Story